 |
|
|
| Internet Search |
|
Stock Search |
|
|
|
|
|
BIOSOURCE INTL IN, (BIOI) Stock Research Free Stock Rating
|
|
| |
| Company Profile |
| |
|
BioSource International, Inc. engages in the development, manufacture, marketing, and distribution of products for understanding disease, and developing new drug therapies and medical diagnostics worldwide. Its products enable biomedical researchers to understand disease processes, as well as the biochemistry, immunology, and cell biology of the human body. The companys products include assay test kits, clinical diagnostic kits, bioactive proteins, antibodies, bioactive peptides, oligonucleotides, serum, media, and related products. It offers naturally occurring or synthetically produced animal- or human-based nucleic acids and proteins, which include monoclonal or polyclonal antibodies, bioactive recombinant proteins, synthetic peptides, or synthetic oligonucleotides. The company offers assay kits, which are a collection of reagents, buffers, calibrators, and active biologicals that are standardized, validated, and assembled into a ready-to-use package of products. Its assay kits are used by researchers to detect and quantitate specific responses in experimental models used to study normal and disease states. The company also offers serum and media products, which provide researchers with a viable and reproducible disease model; an oligonucleotide, a synthesized polymer used in molecular biology made up of the same building blocks that form deoxyribonucleic acid; and radioimmuno-assays, which are sold to clinical diagnostic laboratories for the measurement of hormones and proteins important in endocrinology. The company was incorporated in 1989 and is headquartered in Camarillo, California.
|
|
|
|
|
